Patient | Baseline perfusion (mL/min/g) | Change in perfusion (%) | Baseline FDG-SUV | Change in FDG-SUV at week 2 (%) | Change in FDG-SUV at week 4 (%) | Clinical benefit a | Day 15 trough levels of sunitinib + SU12662 b (ng/mL) | VEGF plasma levels D15:D1 | sVEGFR-2 plasma levels D15:D1 |
---|---|---|---|---|---|---|---|---|---|
1 | 0.81 | −85 | 4.6 | −39 | −48 | Yes | 76.4 | 5.29 | 0.66 |
2 | 1.18 | −77 | 6.5 | −37 | −59 | Yes | 134.9 | 4.85 | 0.44 |
3 | 1.52 | −59 | 4.2 | −33 | −29 | No | 90.8 | 8.67 | 0.34 |
4 | 1.28 | −34 | 9.8 | −44 | −13 | No | 27.6 | 2.56 | 0.75 |
5 | 0.74 | −69 | 12.3 | −67 | −66 | Yes | 107.1 | 4.17 | 0.49 |
6 | 1.39 | −38 | 6.0 | −32 | −18 | Yes | 88.8 | NA | NA |
7 | 1.23 | −20 | 4.1 | −29 | −41 | No | 105.0 | NA | NA |